Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention

International Journal of Obesity

Volumn 40, Issue 5, 2016, Pages 747-753

  Otten, J ^a   Mellberg, C ^a   Ryberg, M ^a   Sandberg, S ^a   Kullberg, J ^b   Lindahl, B ^a   Larsson, C ^c   Hauksson, J ^d   Olsson, T ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; DIETARY INTAKE; ENERGY EXPENDITURE; FEMALE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIVER FAT; LOW FAT DIET; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PALEOLITHIC DIET; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBCUTANEOUS FAT; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; BLOOD PRESSURE; BODY WEIGHT LOSS; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; DIET THERAPY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; LIVER; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SWEDEN; TIME FACTOR; TREATMENT OUTCOME;

LIPID;

BLOOD GLUCOSE; BLOOD PRESSURE; DIET, FAT-RESTRICTED; DIET, PALEOLITHIC; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPIDS; LIVER; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; POSTMENOPAUSE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84958073212     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.4     Document Type: Article

References (40)

1. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014; 383: 970-983.
2. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
3. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-384.
4. Fabbrini E, Yoshino J, Yoshino M, Magkos F, Tiemann Luecking C, Samovski D et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest 2015; 125: 787-795.
5. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008; 134: 1369-1375.
6. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028.
7. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012; 56: 255-266.
8. Haufe S, Haas V, Utz W, Birkenfeld AL, Jeran S, Bohnke J et al. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care 2013; 36: 3786-3792.
9. Jonsson T, Granfeldt Y, Ahren B, Branell UC, Palsson G, Hansson et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol 2009; 8: 35.
10. Mellberg C, Sandberg S, Ryberg M, Eriksson M, Brage S, Larsson C et al. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial. Eur J Clin Nutr 2014; 68: 350-357.
11. Bozzetto L, Prinster A, Annuzzi G, Costagliola L, Mangione A, Vitelli et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 2012; 35: 1429-1435.
12. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013; 59: 138-143.
13. Lindeberg S, Jönsson T, Granfeldt Y, Borgstrand E, Soffman J, Sjöström K et al. A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 2007; 50: 1795-1807.
14. Volzke H, Schwarz S, Baumeister SE, Wallaschofski H, Schwahn C, Grabe HJ et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007; 56: 594-595.
15. Ryberg M, Sandberg S, Mellberg C, Stegle O, Lindahl B, Larsson C et al. A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women. J Intern Med 2013; 274: 67-76.
16. Alexander J, Anderssen SA, Aro A, Becker W, Fogelholm M, Lyhne N et al. Nordic Nutrition Recommendations 2004, Integrating Nutrition and Physical Activity, 4th edn. Copenhagen: Norden: 2004.
17. Stegle O, Fallert SV, MacKay DJ, Brage S. Gaussian process robust regression for noisy heart rate data. IEEE Trans Biomed Eng 2008; 55: 2143-2151.
18. Brage S, Westgate K, Wijndaele K, Godinho J, Griffin S, Wareham N. Evaluation Of A Method For Minimizing Diurnal Information Bias In Objective Sensor Data. 3rd International Conference on Ambulatory Monitoring of Physical Activity and Movement; June 17-19, 2013; Amherst, MA, USA, 2013.
19. Brage S, Ekelund U, Brage N, Hennings MA, Froberg K, Franks PW et al. Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol (1985) 2007; 103: 682-692.
20. Bolinder J, Ljunggren O, Kullberg J, Johansson L, Wilding J, Langkilde AM et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab 2012; 97: 1020-1031.
21. Kullberg J, Ahlstrom H, Johansson L, Frimmel H. Automated and reproducible segmentation of visceral and subcutaneous adipose tissue from abdominal MRI. Int J Obes (Lond) 2007; 31: 1806-1817.
22. Vangipurapu J, Stancakova A, Kuulasmaa T, Paananen J, Kuusisto J, Ferrannini E et al. A novel surrogate index for hepatic insulin resistance. Diabetologia 2011; 54: 540-543.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
24. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001; 24: 539-548.
25. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
26. Otten J, Ahren B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia 2014; 57: 1781-1788.
27. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005; 90: 2804-2809.
28. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 56: 944-951.
29. Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE, Larsson et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 2014; 63: 2356-2368.
30. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010; 52: 774-788.
31. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007; 133: 496-506.
32. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634-642.
33. Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014; 510: 84-91.
34. Bojsen-Moller KN, Dirksen C, Jorgensen NB, Jacobsen SH, Serup AK, Albers PH et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014; 63: 1725-1737.
35. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-2514.
36. Haufe S, Engeli S, Kast P, Bohnke J, Utz W, Haas V et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011; 53: 1504-1514.
37. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 1131-1141.
38. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-1015.
39. Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002; 282: E657-E663.
40. Koda M, Kawakami M, Murawaki Y, Senda M. The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. J Gastroenterol 2007; 42: 897-903.